1. Home
  2. PEBK vs LCTX Comparison

PEBK vs LCTX Comparison

Compare PEBK & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peoples Bancorp of North Carolina Inc.

PEBK

Peoples Bancorp of North Carolina Inc.

HOLD

Current Price

$43.76

Market Cap

232.7M

Sector

Finance

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.04

Market Cap

251.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PEBK
LCTX
Founded
1912
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
232.7M
251.4M
IPO Year
2012
1996

Fundamental Metrics

Financial Performance
Metric
PEBK
LCTX
Price
$43.76
$1.04
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $5.50
AVG Volume (30 Days)
20.6K
★ 1.4M
Earning Date
10-19-2026
11-09-2026
Dividend Yield
★ 1.92%
N/A
EPS Growth
★ 21.48
N/A
EPS
★ 1.76
N/A
Revenue
N/A
★ $14,556,000.00
Revenue This Year
N/A
$4.38
Revenue Next Year
N/A
$10.80
P/E Ratio
$24.95
★ N/A
Revenue Growth
N/A
★ 53.24
52 Week Low
$27.33
$0.88
52 Week High
$45.78
$2.09

Technical Indicators

Market Signals
Indicator
PEBK
LCTX
Relative Strength Index (RSI) 48.91 56.46
Support Level $41.70 $1.02
Resistance Level $45.38 $1.05
Average True Range (ATR) 1.04 0.06
MACD -0.05 0.01
Stochastic Oscillator 50.09 96.66

Price Performance

Historical Comparison
PEBK
LCTX

About PEBK Peoples Bancorp of North Carolina Inc.

Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: